Suppr超能文献

以色列在1957年至1982年这四分之一个世纪里控制脊髓灰质炎的经验。

The Israeli experience in the control of poliomyelitis during a quarter of a century, 1957-1982.

作者信息

Goldblum N, Swartz T

出版信息

Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S313-7. doi: 10.1093/clinids/6.supplement_2.s313.

Abstract

Data are presented on the programs and the results of immunization against paralytic poliomyelitis in Israel during the 25-year period 1957-1982. To control severe outbreaks of the disease, Israel introduced Salk-type inactivated poliovirus vaccine (IPV) on a large scale in 1957 and used it for a period of five years. Vaccination with IPV had a beneficial effect, demonstrably reducing the morbidity from poliomyelitis. In 1961, Sabin's oral poliovirus vaccine ( OPV ) was first used during an epidemic outbreak of the disease and has been in continuous use since. Vaccination with OPV has resulted in a highly significant decrease in the incidence of the disease, although sporadic cases continued to occur. This program was supplemented for the past four years with an annual mass vaccination campaign in "high-risk" areas of the country. These additional preventive measures have resulted in a further reduction in morbidity but not in the complete disappearance of the disease.

摘要

本文呈现了1957年至1982年这25年间以色列针对麻痹性脊髓灰质炎的免疫规划及成果。为控制该疾病的严重疫情,以色列于1957年大规模引入了索尔克型灭活脊髓灰质炎病毒疫苗(IPV),并使用了五年。接种IPV产生了有益效果,显著降低了脊髓灰质炎的发病率。1961年,萨宾口服脊髓灰质炎病毒疫苗(OPV)首次在该病的一次流行爆发期间使用,此后一直持续使用。接种OPV导致该病发病率大幅下降,尽管仍有散发病例出现。在过去四年里,该国在“高危”地区开展了年度大规模疫苗接种活动,以补充这一规划。这些额外的预防措施进一步降低了发病率,但并未使该疾病完全消失。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验